Skip to content

RNA Sequencing of Discarded Tracheal Stenosis Tissue to Characterize Cellular and Molecular Pathogenesis

RNA Sequencing of Discarded Tracheal Stenosis Tissue to Characterize Cellular and Molecular Pathogenesis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07258784
Enrollment
10
Registered
2025-12-02
Start date
2025-09-11
Completion date
2026-12-31
Last updated
2025-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subglottic Stenosis, Tracheal Stenosis

Brief summary

Benign tracheal stenosis is a rare but potentially life-threatening condition, typically resulting from fibroinflammatory scarring. It can be secondary to iatrogenic etiologies such as intubation or tracheostomy , as well as autoimmune diseases and being idiopathic. Patients typically undergoes endoscopic or surgical interventions to open up the airways. This project will analyze resected or biopsied tissue from patients with benign tracheal stenosis to define disease-specific RNA expression profiles.

Interventions

PROCEDUREBiopsy or surgery

The tissue will be obtained from biopsy or surgical resection. All the intervention will be performed for clinical needs. The tissue used in the study will be considered as discarded tissue

Sponsors

University of Maryland, Baltimore
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients with benign tracheal stenosis

Exclusion criteria

* Malignancy. active infection

Design outcomes

Primary

MeasureTime frameDescription
RNA profile1 yearThe diseased mucosa will show a increased fibrosis and inflammation profile compared with that from normal mucosa

Countries

United States

Contacts

Primary ContactChenchen Zhang, MD
chenchen.zhang@som.umaryland.edu14103288141

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026